Multi-ligand modified PC@DOX-PA/EGCG micelles effectively inhibit the growth of ER<sup>+</sup>, PR<sup>+</sup> or HER<sup>2+</sup> breast cancer
Xiaozhen Wang, Jiecheng He, Siyuan Jiang, Yifei Gao, Lingkun Zhang, Liang Yin, Rong You, Yan‐Qing Guan
Abstract
results indicate that the nanoparticles can target BT-474, MCF-7, EMT-6, and MDA-MB-231 breast cancer cells, effectively inhibiting the growth of the breast cancer cells. In short, this research will provide some strategies for the treatment of heterogeneous breast cancer.
Topics & Concepts
MicelleLigand (biochemistry)Materials scienceRadiochemistryNuclear chemistryChemistryPhysical chemistryBiochemistryReceptorAqueous solutionNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRNA Interference and Gene Delivery